Are there any situations where you would consider neoadjuvant chemoradiation as opposed to chemoimmunotherapy for patients with resectable NSCLC prior to surgical resection?
Answer from: Medical Oncologist at Academic Institution
For most of the last 2 decades, there has been a raging debate about the best perioperative approach for the management of patients with high-risk resectable NSCLC, such as patients for example, with preop documented nodal disease. Clinical studies have not been able to settle the key questions whet...
Comments
Medical Oncologist at Joliet Oncology Hematology Associates Excellent commentary, this is extremely helpful. H...
Excellent commentary, this is extremely helpful. H...